Literature DB >> 19079201

Immune privilege or privileged immunity?

J V Forrester1, H Xu, T Lambe, R Cornall.   

Abstract

Immune privilege is a concept that has come of age. Where previously it was considered to be a passive phenomenon restricted to certain specialized tissues, it is now viewed as comprising several mechanisms, both active and passive, shared in many aspects with emerging notions of the mechanisms of peripheral tolerance. The relative degrees of immune privilege vary from tissue to tissue depending on the number and strength of each of the mechanisms contained in that tissue. Immune privilege can be generated in non-privileged sites such as the skin and allografts, and is a property of the tissue itself. We therefore propose that, in addition to canonical central and peripheral tolerance mechanisms, there is a third route whereby the organism promotes self-antigen non-reactivity centered on the specific properties of each tissue and varying accordingly (relative degrees of immune privilege). This third mechanism of inducing immunological tolerance, as it is a local tissue phenomenon, might have particular therapeutic significance, for instance in devising strategies for induction of immunity to tumors by disrupting immune privilege or in preventing graft rejection by promoting immune privilege.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079201     DOI: 10.1038/mi.2008.27

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  45 in total

Review 1.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

Review 2.  Immune Tolerance for Autoimmune Disease and Cell Transplantation.

Authors:  Xunrong Luo; Stephen D Miller; Lonnie D Shea
Journal:  Annu Rev Biomed Eng       Date:  2016-02-24       Impact factor: 9.590

Review 3.  New insights into mononuclear phagocyte biology from the visual system.

Authors:  Nancy J Reyes; Emily G O'Koren; Daniel R Saban
Journal:  Nat Rev Immunol       Date:  2017-03-27       Impact factor: 53.106

Review 4.  Organ-specific protection mediated by cooperation between vascular and epithelial barriers.

Authors:  Ilaria Spadoni; Giulia Fornasa; Maria Rescigno
Journal:  Nat Rev Immunol       Date:  2017-09-04       Impact factor: 53.106

5.  Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege.

Authors:  Xiaojie Wang; Alexandra K Marr; Trisia Breitkopf; Gigi Leung; Jianqiang Hao; Eddy Wang; Nicole Kwong; Noushin Akhoundsadegh; Lieping Chen; Alice Mui; Nicholas Carr; Garth L Warnock; Jerry Shapiro; Kevin J McElwee
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

6.  Fibroblast Growth Factor 2 Enhances Zika Virus Infection in Human Fetal Brain.

Authors:  Daniel Limonta; Juan Jovel; Anil Kumar; Julia Lu; Shangmei Hou; Adriana M Airo; Joaquin Lopez-Orozco; Cheung Pang Wong; Leina Saito; William Branton; Gane Ka-Shu Wong; Andrew Mason; Christopher Power; Tom C Hobman
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

7.  The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition.

Authors:  Ru Zhou; Reiko Horai; Phyllis B Silver; Mary J Mattapallil; Carlos R Zárate-Bladés; Wai Po Chong; Jun Chen; Rachael C Rigden; Rafael Villasmil; Rachel R Caspi
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

Review 8.  Macrophages and dendritic cells in the post-testicular environment.

Authors:  Nicolas Da Silva; Claire R Barton
Journal:  Cell Tissue Res       Date:  2015-09-04       Impact factor: 5.249

Review 9.  Considerations for use of Ebola vaccine during an emergency response.

Authors:  Jenny A Walldorf; Emily A Cloessner; Terri B Hyde; Adam MacNeil
Journal:  Vaccine       Date:  2017-09-07       Impact factor: 3.641

Review 10.  IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.

Authors:  Bana Jabri; Valérie Abadie
Journal:  Nat Rev Immunol       Date:  2015-11-16       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.